Metabolomics is basically the study of metabolites and other micro atomic particles mainly in the biological field. Metabolites are grouped as metabolomes and primarily consist of compounds in cell fluids, tissues, organs, organ systems, and Organisms. Metabolomics is a highly apprehensive research field as it allows a specific framework for metabolites in a diverse range from the micro atomic to the highest level.

The Metabolomics Market has been standing at a market value of USD 1.25 billion as of the year 2016. With scholars preferring a wider and comprehensive scale research, the metabolomics market is gradually getting the boost to kickstart a phenomenal market position. The production of customized medicine has also started accepting metabolomics as a standard development scale, which is further enhancing the performance of the Metabolomics industry in the present market.

The metabolomes market is studied under various segments. These segments are usually made on the basis of product, application, and indication. Like with the study of all other industries, a regional market segregation is also done. On the basis of product, the metabolomics market is divided into Bioinformatics, HPLC, GC, NMRS, Mass Spectrometry.

Bioinformatics has been faring sufficiently well in the present market. According to the indication, the metabolomics market has been categorized into Cardiology, Inborn Errors, and Oncology. On the basis of application, the market is studied under the categories of Toxicology, Nutrigenomics, and Biomarker and Drug Discovery. In the year 2016, the market segment of Biomarker and Drug Discovery held the largest market share in the metabolomics industry.

In the forthcoming years, a lot of factors may affect the performance of the metabolomics industry in the market. As advancement commences in the realm of biotechnology, the metabolomics market is becoming more innovatively designed. This will make its stand in the competitive market a firm one. Consumption of pharmaceutical products has also accelerated in the last decade as more and more people become aware of the medicinal information.

This has played a huge role in paving the way to a successful market value for the metabolomics market. In the previous year, drug discovery and biomarkers have performed exceptionally well in the market. This can be attributed to their reliability as an information tool and an efficient metabolomic scale. With the gradual growth of biotechnology and the merging of pharmaceutical industries with biotechnology may allow a high CAGR to the personalized medical segment.

The global metabolomics market has been segregated into smaller categories on a geographical basis. The categories are North America, Latin America, Europe, Asia – Pacific, and the Middle East and Africa. The highest market share in the metabolomics market is held by North America, as pharmaceutical consumption and medical awareness in this region is high.

In the next forecast season, Asia Pacific may rise as a market leader with its high CAGR and quick pace of growth. The Asia Pacific is the second largest market holder in the global metabolomics market. A high population and their inclination towards biotechnologically manipulated products may steer them towards the top as market leaders.

Most market leaders in the metabolomics industry have their grounds in the United States. Some notable market leaders include Thermo Fisher Scientific, Inc., Metabolon Inc., Waters Corporation, Agilent Technologies, Inc., and Bruker Corporation. Metabolomic companies from the Asia Pacific region have also performed well and remained among the key players.

Major Asian Companies in the metabolomics industry are Human Metabolome Technologies Inc., and Shimadzu Corporation. Both of them belong to Japan. In the European Market, an Austrian Company, Biocrates Life Sciences AG has been performing as a key market player in the metabolomics market.

The CAGR for the upcoming years has been estimated at 19%. Therefore, the global Metabolomics market may reach a market value of USD 2.981 billion by the year 2021.The Filling of gaps for high costs of instruments, the requirement of specialists, and an environmentally conscious effort will definitely give the metabolomics market the momentum it deserves.

Check out Market Data Forecast’s comprehensive reports with in-depth analysis about the Metabolomics Market a free research sample can also be availed. Stay tuned for trending news stories about the latest technologies and interesting Healthcare tit-bits.